FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 338:131-132 January 8, 1998 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article Related Article by Hostetter, T. H. PubMed Citation

To the Editor: Hsu et al. (Sept. 4 issue)¹ describe a method of regional anticoagulation for continuous venovenous hemofiltration that involves the infusion of a citrate-containing replacement fluid. For over a year we have used a similar technique, in which a replacement fluid containing 15 mmol of disodium citrate per liter is infused at a fixed rate of 2 liters per hour, volume control is achieved by variable ultrafiltration, and the blood-flow rate is set at 60 to 150 ml per minute. This approach achieves metabolic control equivalent to that with lactate-based solutions. Correction of acidosis, however, can be insufficient . . . [Full Text of this Article]

References

Related Letters:

Continuous Hemofiltration
Hostetter T. H., Manske C. L., Paller M. S., Hsu C.-y., Palsson R., Niles J. L., van Bommel E. F.H., Grootendorst A. F., Forni L.G., Hilton P.J.
Extract | Full Text  
N Engl J Med 1997; 337:712-714, Sep 4, 1997. Correspondence

This article has been cited by other articles:

• Apsner, R., Gruber, D., Horl, W. H., Sunder-Plassmann, G. (2004). Parathyroid Hormone Secretion During Citrate Anticoagulated Hemodialysis in Acutely Ill Maintenance Hemodialysis Patients. Anesth. Analg. 99: 1199-1204 [Abstract] [Full Text]